Covered recipient · General Payments record
EFIM WEINMAN
General Payments · PY2018–2022
$1,443.80
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $148.72 | 7 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $32.54 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.57 | 1 |
| Neurocrine BioSciences, Inc. | $24.65 | 1 |
| Supernus Pharmaceuticals, Inc. | $22.78 | 1 |
| Almatica Pharma Inc. | $21.58 | 1 |
| Lundbeck LLC | $20.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (7)
Sorted by paying entity, then date · as published by CMS
Program year 2022 2018201920202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.33 | 01/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892625559 | CMS |
| ABBVIE INC. | $13.21 | 02/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892625561 | CMS |
| Almatica Pharma LLC | $21.58 | 01/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 896652865 | CMS |
| Lundbeck LLC | $20.60 | 02/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945814319 | CMS |
| Neurocrine Biosciences, Inc. | $24.65 | 08/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 963434821 | CMS |
| Supernus Pharmaceuticals, Inc. | $22.78 | 02/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 953028197 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.57 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 955872761 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.